Mylan hires Julie Bowen in anaphylaxis campaign
BASKING RIDGE, N.J. — A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.
Mylan Specialty announced the Raise Your Hand for Anaphylaxis Awareness campaign, hiring actress Julie Bowen as a celebrity spokeswoman. The campaign will invite people to virtually "raise their hands" for their school districts by visiting www.Anaphylaxis101.com; four winning school districts will receive grants of $15,000 to support educational programs.
"Since I joined the Get Schooled in Anaphylaxis campaign and started sharing my experience of raising a child with life-threatening allergies, so many people have in turn shared their personal stories with me," Bowen said. "It’s been a real eye opener to realize how many parents, like me, didn’t know their child had life-threatening allergies until anaphylaxis occurred."
Great idea to help educate students about food allergies. During these events, please also help promote among food allergic students the importance of self carrying their Epipens. In the US almost all states have passed the self carrying epinephrine law but many students aren't aware of it and those that know about it aren't carrying them because the injectors are to big to put inside their pockets. There are discreet epipen carriers and concealed epipen holsters and even undergarment waist slings that make it easy to self carry their epinephrine so they need to also be informed about these solutions.
Beauty spells opportunity for retail-pharmacy operators
AccentHealth found that more than half of viewers make personal product purchases when filling a prescription at the pharmacy, according to an online survey of almost 700 AccentHealth viewers conducted in April. There is opportunity for growth as 7-out-of-10 consumers indicated that they are likely to purchase beauty and hygiene products when filling a prescription in the future.
To see more Patient Views, click here
Patient Views is a new, exclusive consumer insights feature that appears in every edition of DSN magazine, as well as the daily e-newsletter DSN A.M. If you could ask 6,000 patients anything at all, what would it be? Send your questions to email@example.com.
Source: AccentHealth. To view the demographic breakdown of participants, click here.
No comments found
Vitamin C kills drug-resistant TB, researchers find
NEW YORK — Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.
The researchers, at Yeshiva University’s Albert Einstein College of Medicine, determined that vitamin C was able to kill drug-resistant forms of the bacteria that causes tuberculosis in lab culture, publishing their findings in the online journal Nature Communications. They had been looking into how TB bacteria become resistant to isoniazid, a first-line drug used to treat it.
TB sickened 8.7 million people around the world and resulted in 1.4 million deaths, according to the World Health Organization, and about 650,000 people have multi-drug-resistant forms of the bacteria.
No comments found